1YOSIPOVITCH G,HOON T S,LEOK G C.Suggested rationale for prevention and treatment of glucocorticoid induced bone loss in dermatologic patients[J].Arch Dermatol,2001,137(4):477-481.
2YOOD R A,HARROLD I R,FISH L,et al .Prevention of glucocorticoid induced osteoporosis [J].Arch Intern Med,2001,161(5):1322-1327.
3BUCKLEY L M,LEIB E S,CARTULARO K S,et al.Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low dose corticosteroids in patients with rheumatoid arthritis[J].Ann Intern Med,1996,125(12):961-968.
4ADACHI J D,BENSEN W G,BIANCHI F,et al.Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis:a three year follow-up[J].J Rheumatol,1996,23(6):995-1000.
5LANE N E,Lukert B.The science and therapy of glucocorticoid-induced bone loss[J].Endocrinol Metab Clin North Am,1998,27(2):465-483.
6PITT P,LI F,TODD P,et al.A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long term oral corticosteroid treatment[J].Thorax,1998,53(5):351-356.
7ADACHI J D,BENSEN W G,BROWN J,et al .Intermittent etidronate therapy to prevent corticosteroid induced osteoporosis[J].N Engl J Med,1997,337(6):382-387.
8SAAG K G,EMKEY R,SCHNITZER T J,et al.Alendronate for the prevention and treatment of glucocorticoid induced osteoporosis[J].N Engl J Med,1998,339(5):292-299.
9ADACHI J D,SAAG K G,DELMAS P D,et al .Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids:a randomized,double-blind,placebo-controlled extension trial [J].Arthritis Rheum,2001,44(1):202-211.
10DUNN C J,GOA K L.Risedronate:a review of its pharmacological properties and clinical use in resorptive bone disease[J].Drugs,2001,61(5):685-712.
8Hirayama T, Sabokbar A, Athanasou NA. Effect of corticosteroids on human osteoclast formation and activity[ J]. J Endocrinol, 2002,175( 1 ) : 155 - 163.
9Durieux S, Mercadal L, Oreel P, et al. Bone mineral density and fracture prevalence in long-term kidney graft recipients[J] .Transplantation, 2002,74(4) :496 - 500.
10Yood RA, Harrold LR, Fish L, et al. Prevention of glucocorticoid induced osteoporosis [ J]. Arch Intern Med, 2001,161(5) : 1322 - 1327.
